Methylation-Based Therapies for Colorectal Cancer
Open accessThe DOI matches its Crossref record; 236 of the 241 references it cites were found in a registry or an index.
Abstract
Colorectal carcinogenesis (CRC) is caused by the gradual long-term accumulation of both genetic and epigenetic changes. Recently, epigenetic alterations have been included in the classification of the CRC molecular subtype, and this points out their prognostic impact. As epigenetic modifications are reversible, they may represent relevant therapeutic targets. DNA methylation, catalyzed by DNA methyltransferases (DNMTs), regulates gene expression. For many years, the deregulation of DNA methylation has been considered to play a substantial part in CRC etiology and evolution. Despite considerable advances in CRC treatment, patient therapy response persists as limited, and their profit from systemic therapies are often hampered by the introduction of chemoresistance. In addition, inter-individual changes in therapy response in CRC patients can arise from their specific (epi)genetic compositions. In this review article, we summarize the options of CRC treatment based on DNA methylation status for their predictive value. This review also includes the therapy outcomes based on the patient’s methylation status in CRC patients. In addition, the current challenge of research is to develop therapeutic inhibitors of DNMT. Based on the essential role of DNA methylation in CRC development, the application of DNMT inhibitors was recently proposed for the treatment of CRC patients, especially in patients with DNA hypermethylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, excessive demethylation by DNMT inhibitors can also disrupt normal gene expression patterns and cause toxicity [158].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [158]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–236 of 236
Dienstmann, R., Salazar, R., & Tabernero, J. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.91 · Cited by 38
Morano, F., Corallo, S., Niger, M., Barault, L., Milione, M., Berenato, R., Moretto, R., Randon, G., Antista, M., Belfiore, A., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy197 · Cited by 38
Sharma, A. R., Vatapalli, R. J., Abdelfatah, E., McMahon, K. W., Kerner, Z. J., Guzzetta, A. A., Singh, J., Zahnow, C. A., Baylin, S. B., Yerram, S. R., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176139 · Cited by 38
CDH13 and FLBN3 Gene Methylation are Associated with Poor Prognosis in Colorectal Cancer
Wang, Z., Yuan, X., Jiao, N., Zhu, H., Zhang, Y., & Tong, J. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9437-0 · Cited by 37
Matsunoki, A., Kawakami, K., Kotake, M., Kaneko, M., Kitamura, H., Ooi, A., Watanabe, G., & Minamoto, T. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-574 · Cited by 36
Bender, U., Rho, Y. S., Barrera, I., Aghajanyan, S., Acoba, J., & Kavan, P. (2019) · Current Oncology · doi:10.3747/co.26.5605 · Cited by 36
Suicidal function of DNA methylation in age-related genome disintegration
Mazin, A. L. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.04.005 · Cited by 36 · cited 1×
“DNA methylation is an endogenous source of mutations and thus contributes to mutation burden, causing DNA damage and leading to apoptosis and the aging or death of the organism [21].”
BackgroundWettergren, Y., Odin, E., Nilsson, S., Carlsson, G. U., & Gustavsson, B. G. (2008) · Molecular Medicine · doi:10.2119/2007-00096.wettergren · Cited by 35
Jansen, Y. J. L., Verset, G., Schats, K., van Dam, P., Seremet, T., Kockx, M. M., Laethem, J.-L. B. V., & Neyns, B. (2019) · ESMO Open · doi:10.1136/esmoopen-2018-000464 · Cited by 34
Epigenome-Wide Analysis of DNA Methylation Reveals a Rectal Cancer-Specific Epigenomic Signature
Vymetalkova, V. P., Vodička, P., Pardini, B., Rosa, F., Levý, M., Schneiderová, M., Liška, V., Vodičková, Ľ., Nilsson, T., & Farkas, S. A. (2016) · Epigenomics · doi:10.2217/epi-2016-0044 · Cited by 34
Self-citationThe Controversial Denouement of Vertebrate DNA Methylation Research
Ehrlich, M. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0150-z · Cited by 33
Pietrantonio, F., Lobefaro, R., Antista, M., Lonardi, S., Raimondi, A., Morano, F., Mosconi, S., Rimassa, L., Murgioni, S., Bianchi, A. S., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3024 · Cited by 32
Marisa, L., Ayadi, M., Balogoun, R., Pilati, C., Malicot, K. L., Lepage, C., Emile, J., Salazar, R., Aust, D. E., Duval, A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.3509 · Cited by 32
Kaneko, M., Kotake, M., Bando, H., Yamada, T., Takemura, H., & Minamoto, T. (2016) · BMC Cancer · doi:10.1186/s12885-016-2984-8 · Cited by 30
Cohen, S. A., Wu, C., Yu, M., Gourgioti, G., Wirtz, R., Raptou, G., Gkakou, C., Kotoula, V., Pentheroudakis, G. E., Papaxoinis, G., et al. (2015) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2015.10.005 · Cited by 30
PIK3CA mutation and methylation influences the outcome of colorectal cancer
Iida, S., Kato, S., Ishiguro, M., Matsuyama, T., Ishikawa, T., Kobayashi, H., Higuchi, T., Uetake, H., Enomoto, M., & Sugihara, K. (2011) · Oncology Letters · doi:10.3892/ol.2011.544 · Cited by 29
Sun, X., Yuan, W., Hao, F., & Zhuang, W. (2017) · Medical Science Monitor · doi:10.12659/msm.903927 · Cited by 29
Methylation epigenotypes and genetic features in colorectal laterally spreading tumors
Sakai, E., Ohata, K., Chiba, H., Matsuhashi, N., Doi, N., Fukushima, J., Endo, H., Takahashi, H., Tsuji, S., Yagi, K., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28814 · Cited by 29
IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers
Fu, T., Pappou, E. P., Guzzetta, A. A., Calmon, M. F., Sun, L., Herrera, A., Li, F., Wolfgang, C. L., Baylin, S. B., Iacobuzio–Donahue, C. A., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001204 · Cited by 27
Methylated BNIP3 gene in colorectal cancer prognosis
Shimizu, S., Iida, S., Ishiguro, M., Uetake, H., Ishikawa, T., Takagi, Y., Kobayashi, H., Higuchi, T., Enomoto, M., Mogushi, K., et al. (2010) · Oncology Letters · doi:10.3892/ol_00000153 · Cited by 26
Kim, S. H., Park, K. H., Shin, S. J., Lee, K. Y., Kim, T. I., Kim, N. K., Rha, S. Y., & Ahn, J. B. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.5.588 · Cited by 25
Jensen, L. H., Rasmussen, A. A., Byriel, L., Kuramochi, H., Crüger, D. G., Lindebjerg, J., Danenberg, P. V., Jakobsen, A. K. M., & Danenberg, K. D. (2013) · Cellular Oncology · doi:10.1007/s13402-013-0148-2 · Cited by 25
Jiang, G., Lin, J., Wang, W., Sun, M., Kuisheng, C., & Wang, F. (2017) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2016.0162 · Cited by 24
Pfütze, K., Benner, A., Hoffmeister, M., Jansen, L., Yang, R., Bläker, H., Herpel, E., Ulrich, A. B., Ulrich, C. M., Chang-Claude, J. C., et al. (2015) · Genomics · doi:10.1016/j.ygeno.2015.10.002 · Cited by 21
Kuan, J.-C., Wu, C.-C., Sun, C. A., Chu, C. M., Fu, L., Hsu, C., Kan, P.-C., Lin, S., Yang, T., & Chou, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123396 · Cited by 21
DNA methylation epigenotype and clinical features of NRAS‐mutation(+) colorectal cancer
Takane, K., Akagi, K., Fukuyo, M., Yagi, K., Takayama, T., & Kaneda, A. (2017) · Cancer Medicine · doi:10.1002/cam4.1061 · Cited by 21
Chang, S., Kuo, C.-C., Wu, C., Hsiao, C., Hu, J., Hsu, C., Chou, Y., Shih, Y., & Lin, Y. (2018) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22529 · Cited by 21
Miladi-Abdennadher, I., Abdelmaksoud‐Dammak, R., Ayadi, L., Khabir, A., Frikha, F., Kallel, L., Frikha, M., Sellami‐Boudawara, T., Gargouri, A. F., & Mokdad‐Gargouri, R. (2010) · Bioscience Reports · doi:10.1042/bsr20100023 · Cited by 19
Cheray, M., Pacaud, R., Hervouet, É., Vallette, F. M., & Cartron, P. (2015) · Epigenetic Diagnosis & Therapy · doi:10.2174/2214083201666150221002056 · Cited by 18
Cha, Y., Kim, S. Y., Yeo, H. Y., Baek, J. Y., Choi, M. K., Jung, K. H., Dong, S. M., & Chang, H. J. (2018) · Neoplasia · doi:10.1016/j.neo.2018.11.010 · Cited by 16
Pharmacoepigenetics in gastrointestinal tumors em MGMT em methylation and beyond
Fornaro, L. (2016) · Frontiers in Bioscience-Elite · doi:10.2741/e758 · Cited by 13
Kim, S. H., Park, K. H., Shin, S. J., Lee, K. Y., Kim, T. I., Kim, N. K., Rha, S. Y., Roh, J. K., & Ahn, J. B. (2015) · Cancer Research and Treatment · doi:10.4143/crt.2014.314 · Cited by 13
Büchler, T., Chloupková, R., Poprach, A., Fiala, O., Kišš, I., Kopečková, K., Dušek, L., Veškrňová, V., Slavicek, L., Kohoutek, M., et al. (2018) · Cancer Management and Research · doi:10.2147/cmar.s183093 · Cited by 9
Chapter Nutrients and DNA methylation
Choi, S., Corrocher, R., & Friso, S. (2009) · CRC Press eBooks · doi:10.1201/9781420063561.ch5 · Cited by 9 · cited 1×
“Dietary factors may affect one-carbon metabolisms, including B vitamins, which are coenzymes in one-carbon metabolisms (vitamins B2, B6, and B12) and might be considered as the regulators of DNA methylation [18].”
BackgroundTranscriptional Corepressors: Mediators of Eukaryotic Gene Repression
Privalsky, M. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-10595-5 · Cited by 5 · cited 1×
“The role of MBPs is to bind symmetrically to the methylated CpG to attract different members of the chromatin remodeling complex [70].”
BackgroundKuang, C., Park, Y., Bahary, N., Sun, W., Ohr, J. P., Rhee, J. C., Marks, S. M., Beasley, H. S., Shuai, Y., Lin, Y., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.4_suppl.173 · Cited by 4
Research works printed but not linked: 1
- Vaiserman, A.M. (2017). Epigenetics of Aging and Longevity, Academic Press. [1st ed.].
Cited by
Epigenetics-targeted drugs: current paradigms and future challenges
Dai, W., Qiao, X., Fang, Y., Guo, R., Bai, P., Liu, S., Li, T., Jiang, Y., Wei, S., Na, Z., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02039-0 · Cited by 339
Fatma, H., Maurya, S. K., & Siddique, H. R. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.008 · Cited by 177
Epigenetic Mechanisms of Aging and Aging-Associated Diseases
la Torre, A., Vecchio, F. L., & Greco, A. (2023) · Cells · doi:10.3390/cells12081163 · Cited by 150
“An example is represented by colorectal cancer (CRC) that often affects people over 50 years of age [85].”
BackgroundInfluentialGenetic and epigenetic dependencies in colorectal cancer development
Parmar, S., & Easwaran, H. (2022) · Gastroenterology report · doi:10.1093/gastro/goac035 · Cited by 99
Filip, S., Vymetalkova, V. P., Petera, J., Vodičková, Ľ., Kubeček, O., John, S., Čečka, F., Krupova, M., Manethová, M., Červená, K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155255 · Cited by 97
Self-citation
Metadata
- Authors
- Cervena, K., Siskova, A., Buchler, T., Vodicka, P., & Vymetalkova, V.
- Affiliations
- Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Videnska 1083, 14 200 Prague, Czech Republic
- Charles University (CZ)
- Department of Oncology, First Faculty of Medicine, Charles University and Thomayer Hospital, Videnska 800, 140 59 Prague, Czech Republic
- Corresponding author
- Vymetalkova, Veronika
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-06-24
- Volume
- 9
- Issue
- 6
- Pages
- 1540
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7349319
- OpenAlex
- W3038126636
- Cited by
- 57
- References
- 241
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 16 · 2023: 7 · 2022: 11 · 2021: 5 · 2020: 4
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Grant Agency of the Ministry of Health of the Czech Republic (AZV 17-30920A and NV19-09-00237)
- Charles University Research Centre (UNCE/MED/006)
- Grant Agency of the Charles University (GAUK 302119)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- colorectal cancer, DNA methylation, DNA methyltransferases, DNMT inhibitors, epigenetic therapy, DNA hypermethylation, chemoresistance, predictive biomarkers, molecular subtypes, epigenetic modifications
- MeSH terms
- Humans, Colorectal Neoplasms, DNA Methylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Figure 1 Consensus molecular subtypes (CMS) classification as proposed by Guinney et al. [131].](https://figures.cochat.ai/paper-figures/963c902904204d22894d0af4c77fd8c1/methylation-based-therapies-for-colorectal-cancer-figure-1.jpg)
